Federico Aucejo, MD

home / authors / federico-aucejo-md

Articles

What Is the Indication for Sorafenib in Hepatocellular Carcinoma? A Clinical Challenge

Richard Kim, MD;Michael T. Byrne, DO;Ann Tan, MD;Federico Aucejo, MD

March 15th 2011

In this review article we will discuss the current data on, and future role of, sorafenib in the treatment of hepatocellular carcinoma beyond Child-Pugh A cirrhosis, in conjunction with local therapy, and in a transplant setting.

Adjuvant Treatment After Orthotopic Liver Transplantation: Is It Really Necessary?

Richard Kim, MD;Ann Tan, MD;Bassam Estfan, MD;Federico Aucejo, MD

December 16th 2009

This review summarizes the current data on efficacy and rationale of adjuvant treatment for hepatocellular cancer after orthotopic liver transplantation, as well as future prospects. No adjuvant treatment is currently advocated.